Treat to target: Clinical Trials

3 trials of Treat to target, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1

Follow Treat to target: new trials by email Literature Review of Treat to target trials Research Report on Treat to target

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
Treat to target - Chronic Kidney Disease Mineral and Bone Disorder
Not applicableRecruitingHerlev Hospital702025-11-202026-01-06
Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study
Treat to target - Rheumatoid Arthritis
UnknownChinese University of Hong Kong1102020-07-122023-09-06
Treat Stroke to Target
Target : 100 mg/dL (+/-10 mg/dL), 70 mg/dL - Ischemic Stroke, Transient Ischemic Attack
Not applicableCompletedAssistance Publique - Hôpitaux de Paris28732010-03-152019-08-06

Conditions studied

Arthritis, Rheumatoid (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Ischemic Attack, Transient (1)  ·  Ischemic Stroke (1)  ·  Renal Insufficiency, Chronic (1)  ·  Stroke (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Chinese University of Hong Kong (1)  ·  Herlev Hospital (1)

Countries

Denmark (1)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Ditte Hansen, Medical doctor, professor (1)  ·  Lai Shan Tam, MD (1)  ·  Pierre Amarenco, MD (1)

Results publications

PMID 31738483, PMID 31984235, PMID 32078484, PMID 32594766, PMID 33980690, PMID 34963300, PMID 36154103, PMID 37376989